Author

Linge Deng

Observed names: L. Deng, Liurui Deng, Li‐Cong Deng

Institutions: Hunan Normal University, Xi'an Jiaotong University

Observed institutions: Hunan Normal University, Tang Du Hospital, Xi'an Jiaotong University, Air Force Medical University

ORCID: 0009-0004-8632-2912

Observed ORCID: 0009-0004-8632-2912

OpenAlex ID: A5113098120

MA11.06 A PII Study of Toripalimab, a PD-1 mAb, in Combination with Chemotherapy in EGFR+ Advanced NSCLC Patients Failed to Prior EGFR TKI Therapies

2019 · J. Zhang, C. Zhou, et al. · Journal of Thoracic Oncology · 26

KIT-SNAP-tag/cell membrane chromatography model coupled with liquid chromatography–mass spectrometry for anti-GIST compound screening from Evodia rutaecarpa

2024 · Jingting Feng, Yuhan Jiang, et al. · Analytical and Bioanalytical Chemistry · 10

Tripterygium wilfordii Hook F derived active ingredients alleviate anaphylactoid reactions via MAS-related G protein-coupled receptor X2

2025 · Na Guo, Haoyun Bai, et al. · Talanta · 3

Optimal decision of low-carbon supply chains with carbon tax incentives and differentiated carbon taxes

2025 · Liurui Deng, Ying Zhang, et al. · Expert Systems with Applications · 1

Randomized, double‐blind phase III trial of a dexamethasone‐free regimen for managing highly emetogenic chemotherapy‐induced nausea and vomiting

2025 · Shi Chen, Yi‐Yan Pei, et al. · International Journal of Cancer · 1

Works count: 5

Citation count: 41

H-index: 3

I10-index: 2